clinical trial · NCT07353957
Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer
Merus B.V.·phase2·withdrawn
Lung Cancer - Non Small Cell SquamousLung Cancer - Non Small Cell Non-SquamousPetosemtamab + Pembrolizumab
brief summary
The study will test the efficacy and safety of petosemtamab in combination with Pembrolizumab in first line patients with squamous non-small cell lung cancer and non-squamous non-small cell lung cancer.
started
Mar 27, 2025
primary completion
May 31, 2028
completion
Feb 27, 2031
last updated
Jul 2, 2026
official title
A Phase 2 Study to Investigate the Safety and Efficacy of Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer in Combination With Pembrolizumab as First-Line Treatment
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol